ArticleEClinicalMedicine2020

Clinical characteristics and outcomes among hospitalized adults with severe COVID-19 admitted to a tertiary medical center and receiving antiviral, antimalarials, glucocorticoids, or immunomodulation with tocilizumab or cyclosporine: A retrospective observational study (COQUIMA cohort).

Pablo Guisado-Vasco et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.